Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
J Cell Sci ; 136(2)2023 01 15.
Article in English | MEDLINE | ID: mdl-36655611

ABSTRACT

Proteins entering the secretory pathway need to attain native disulfide pairings to fold correctly. For proteins with complex disulfides, this process requires the reduction and isomerisation of non-native disulfides. Two key members of the protein disulfide isomerase (PDI) family, ERp57 and ERdj5 (also known as PDIA3 and DNAJC10, respectively), are thought to be required for correct disulfide formation but it is unknown whether they act as a reductase, an isomerase or both. In addition, it is unclear how reducing equivalents are channelled through PDI family members to substrate proteins. Here, we show that neither enzyme is required for disulfide formation, but ERp57 is required for isomerisation of non-native disulfides within glycoproteins. In addition, alternative PDIs compensate for the absence of ERp57 to isomerise glycoprotein disulfides, but only in the presence of a robust reductive pathway. ERdj5 is required for this alternative pathway to function efficiently indicating its role as a reductase. Our results define the essential cellular functions of two PDIs, highlighting a distinction between formation, reduction and isomerisation of disulfide bonds.


Subject(s)
Oxidoreductases , Protein Disulfide-Isomerases , Protein Disulfide-Isomerases/genetics , Protein Disulfide-Isomerases/chemistry , Protein Disulfide-Isomerases/metabolism , Oxidoreductases/metabolism , Protein Folding , Glycoproteins/metabolism , Disulfides/metabolism , Oxidation-Reduction
2.
Proc Natl Acad Sci U S A ; 119(12): e2122657119, 2022 03 22.
Article in English | MEDLINE | ID: mdl-35286189

ABSTRACT

SignificanceMembrane and secretory proteins are synthesized in the endoplasmic reticulum (ER). Perturbations to ER function disrupts protein folding, causing misfolded proteins to accumulate, a condition known as ER stress. Cells adapt to stress by activating the unfolded protein response (UPR), which ultimately restores proteostasis. A key player in the UPR response is ATF6α, which requires release from ER retention and modulation of its redox status during activation. Here, we report that ER stress promotes formation of a specific ATF6α dimer, which is preferentially trafficked to the Golgi for processing. We show that ERp18 regulates ATF6α by mitigating its dimerization and trafficking to the Golgi and identify redox-dependent oligomerization of ATF6α as a key mechanism regulating its function during the UPR.


Subject(s)
Endoplasmic Reticulum , Unfolded Protein Response , Dimerization , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum Stress , Oxidation-Reduction , Proteins/metabolism
3.
J Cell Sci ; 134(22)2021 11 15.
Article in English | MEDLINE | ID: mdl-34734627

ABSTRACT

N-linked glycosylation of proteins entering the secretory pathway is an essential modification required for protein stability and function. Previously, it has been shown that there is a temporal relationship between protein folding and glycosylation, which influences the occupancy of specific glycosylation sites. Here, we used an in vitro translation system that reproduces the initial stages of secretory protein translocation, folding and glycosylation under defined redox conditions. We found that the efficiency of glycosylation of hemopexin was dependent upon a robust NADPH-dependent cytosolic reductive pathway, which could be mimicked by the addition of a membrane-impermeable reducing agent. We identified a hypoglycosylated acceptor site that is adjacent to a cysteine involved in a short-range disulfide. We show that efficient glycosylation at this site is influenced by the cytosolic reductive pathway acting on both STT3A- and STT3B-dependent glycosylation. Our results provide further insight into the important role of the endoplasmic reticulum redox conditions in glycosylation site occupancy and demonstrate a link between redox conditions in the cytosol and glycosylation efficiency.


Subject(s)
Oxidoreductases , Cytosol , Glycosylation
4.
J Cell Sci ; 133(8)2020 04 30.
Article in English | MEDLINE | ID: mdl-32184267

ABSTRACT

Folding of proteins entering the mammalian secretory pathway requires the insertion of the correct disulfides. Disulfide formation involves both an oxidative pathway for their insertion and a reductive pathway to remove incorrectly formed disulfides. Reduction of these disulfides is crucial for correct folding and degradation of misfolded proteins. Previously, we showed that the reductive pathway is driven by NADPH generated in the cytosol. Here, by reconstituting the pathway using purified proteins and ER microsomal membranes, we demonstrate that the thioredoxin reductase system provides the minimal cytosolic components required for reducing proteins within the ER lumen. In particular, saturation of the pathway and its protease sensitivity demonstrates the requirement for a membrane protein to shuttle electrons from the cytosol to the ER. These results provide compelling evidence for the crucial role of the cytosol in regulating ER redox homeostasis, ensuring correct protein folding and facilitating the degradation of misfolded ER proteins.


Subject(s)
Membrane Proteins , Thioredoxin-Disulfide Reductase , Animals , Cytosol , Endoplasmic Reticulum/genetics , Endoplasmic Reticulum/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Oxidation-Reduction , Protein Folding , Thioredoxin-Disulfide Reductase/genetics , Thioredoxin-Disulfide Reductase/metabolism
5.
EMBO J ; 38(15): e100990, 2019 08 01.
Article in English | MEDLINE | ID: mdl-31368601

ABSTRACT

Activation of the ATF6α signaling pathway is initiated by trafficking of ATF6α from the ER to the Golgi apparatus. Its subsequent proteolysis releases a transcription factor that translocates to the nucleus causing downstream gene activation. How ER retention, Golgi trafficking, and proteolysis of ATF6α are regulated and whether additional protein partners are required for its localization and processing remain unresolved. Here, we show that ER-resident oxidoreductase ERp18 associates with ATF6α following ER stress and plays a key role in both trafficking and activation of ATF6α. We find that ERp18 depletion attenuates the ATF6α stress response. Paradoxically, ER stress accelerates trafficking of ATF6α to the Golgi in ERp18-depleted cells. However, the translocated ATF6α becomes aberrantly processed preventing release of the soluble transcription factor. Hence, we demonstrate that ERp18 monitors ATF6α ER quality control to ensure optimal processing following trafficking to the Golgi.


Subject(s)
Activating Transcription Factor 6/genetics , Activating Transcription Factor 6/metabolism , Protein Disulfide Reductase (Glutathione)/metabolism , Transcriptional Activation , Cell Line , Cell Nucleus/metabolism , Endoplasmic Reticulum/metabolism , Gene Deletion , Golgi Apparatus/metabolism , HEK293 Cells , Humans , Signal Transduction , Unfolded Protein Response
6.
J Biol Chem ; 292(17): 6978-6986, 2017 04 28.
Article in English | MEDLINE | ID: mdl-28298446

ABSTRACT

The relationship between protein synthesis, folding, and disulfide formation within the endoplasmic reticulum (ER) is poorly understood. Previous studies have suggested that pre-existing disulfide links are absolutely required to allow protein folding and, conversely, that protein folding occurs prior to disulfide formation. To address the question of what happens first within the ER, that is, protein folding or disulfide formation, we studied folding events at the early stages of polypeptide chain translocation into the mammalian ER using stalled translation intermediates. Our results demonstrate that polypeptide folding can occur without complete domain translocation. Protein disulfide isomerase (PDI) interacts with these early intermediates, but disulfide formation does not occur unless the entire sequence of the protein domain is translocated. This is the first evidence that folding of the polypeptide chain precedes disulfide formation within a cellular context and highlights key differences between protein folding in the ER and refolding of purified proteins.


Subject(s)
Endoplasmic Reticulum/metabolism , Protein Disulfide-Isomerases/chemistry , Protein Folding , Animals , Cell Line, Tumor , Cell-Free System , Codon , Computational Biology , Cross-Linking Reagents/chemistry , Crystallography, X-Ray , Disulfides/chemistry , Dogs , Glycosylation , Humans , Pancreas/metabolism , Peptides/chemistry , Protein Denaturation , Protein Domains , Protein Transport , beta 2-Microglobulin/chemistry
7.
EMBO J ; 36(5): 693-702, 2017 03 01.
Article in English | MEDLINE | ID: mdl-28093500

ABSTRACT

Folding of proteins entering the secretory pathway in mammalian cells frequently requires the insertion of disulfide bonds. Disulfide insertion can result in covalent linkages found in the native structure as well as those that are not, so-called non-native disulfides. The pathways for disulfide formation are well characterized, but our understanding of how non-native disulfides are reduced so that the correct or native disulfides can form is poor. Here, we use a novel assay to demonstrate that the reduction in non-native disulfides requires NADPH as the ultimate electron donor, and a robust cytosolic thioredoxin system, driven by thioredoxin reductase 1 (TrxR1 or TXNRD1). Inhibition of this reductive pathway prevents the correct folding and secretion of proteins that are known to form non-native disulfides during their folding. Hence, we have shown for the first time that mammalian cells have a pathway for transferring reducing equivalents from the cytosol to the ER, which is required to ensure correct disulfide formation in proteins entering the secretory pathway.


Subject(s)
Disulfides/metabolism , Endoplasmic Reticulum/enzymology , Thioredoxin Reductase 1/metabolism , Cell Line , Humans , NADP/metabolism
8.
Biochem J ; 473(7): 851-8, 2016 Apr 01.
Article in English | MEDLINE | ID: mdl-26772871

ABSTRACT

The membrane topology of vitamin K epoxide reductase (VKOR) is controversial with data supporting both a three transmembrane and a four transmembrane model. The positioning of the transmembrane domains and the loops between these domains is critical if we are to understand the mechanism of vitamin K oxidation and its recycling by members of the thioredoxin family of proteins and the mechanism of action of warfarin, an inhibitor of VKOR. Here we show that both mammalian VKOR isoforms adopt the same topology, with the large loop between transmembrane one and two facing the lumen of the endoplasmic reticulum (ER). We used a redox sensitive green fluorescent protein (GFP) fused to the N- or C-terminus to show that these regions face the cytosol, and introduction of glycosylation sites along with mixed disulfide formation with thioredoxin-like transmembrane protein (TMX) to demonstrate ER localization of the major loop. The topology is identical with the bacterial homologue from Synechococcussp., for which the structure and mechanism of recycling has been characterized. Our results provide a resolution to the membrane topology controversy and support previous results suggesting a role for members of the ER protein disulfide isomerase (PDI) family in recycling VKOR.


Subject(s)
Bacterial Proteins/chemistry , Cell Membrane/chemistry , Synechococcus/chemistry , Vitamin K Epoxide Reductases/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Line , Cell Membrane/genetics , Cell Membrane/metabolism , Humans , Protein Structure, Secondary , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Synechococcus/genetics , Synechococcus/metabolism , Vitamin K Epoxide Reductases/genetics , Vitamin K Epoxide Reductases/metabolism
9.
PLoS One ; 10(3): e0119718, 2015.
Article in English | MEDLINE | ID: mdl-25803307

ABSTRACT

We have previously shown that Annexin A8 (ANXA8) is strongly associated with the basal-like subgroup of breast cancers, including BRCA1-associated breast cancers, and poor prognosis; while in the mouse mammary gland AnxA8 mRNA is expressed in low-proliferative isolated pubertal mouse mammary ductal epithelium and after enforced involution, but not in isolated highly proliferative terminal end buds (TEB) or during pregnancy. To better understand ANXA8's association with this breast cancer subgroup we established ANXA8's cellular distribution in the mammary gland and ANXA8's effect on cell proliferation. We show that ANXA8 expression in the mouse mammary gland was strong during pre-puberty before the expansion of the rudimentary ductal network and was limited to a distinct subpopulation of ductal luminal epithelial cells but was not detected in TEB or in alveoli during pregnancy. Similarly, during late involution its expression was found in the surviving ductal epithelium, but not in the apoptotic alveoli. Double-immunofluorescence (IF) showed that ANXA8 positive (+ve) cells were ER-alpha negative (-ve) and mostly quiescent, as defined by lack of Ki67 expression during puberty and mid-pregnancy, but not terminally differentiated with ∼15% of ANXA8 +ve cells re-entering the cell cycle at the start of pregnancy (day 4.5). RT-PCR on RNA from FACS-sorted cells and double-IF showed that ANXA8+ve cells were a subpopulation of c-kit +ve luminal progenitor cells, which have recently been identified as the cells of origin of basal-like breast cancers. Over expression of ANXA8 in the mammary epithelial cell line Kim-2 led to a G0/G1 arrest and suppressed Ki67 expression, indicating cell cycle exit. Our data therefore identify ANXA8 as a potential mediator of quiescence in the normal mouse mammary ductal epithelium, while its expression in basal-like breast cancers may be linked to ANXA8's association with their specific cells of origin.


Subject(s)
Annexins/metabolism , Cell Cycle Checkpoints/physiology , Endothelial Progenitor Cells/metabolism , Gene Expression Regulation, Developmental/physiology , Mammary Glands, Animal/metabolism , Age Factors , Animals , Blotting, Western , Bromodeoxyuridine , Colony-Forming Units Assay , Female , Flow Cytometry , Fluorescent Antibody Technique , Immunohistochemistry , Ki-67 Antigen/metabolism , Mammary Glands, Animal/cytology , Mammary Glands, Animal/growth & development , Mice , Pregnancy , Proto-Oncogene Proteins c-kit/metabolism , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
10.
Mol Cell ; 50(6): 793-804, 2013 Jun 27.
Article in English | MEDLINE | ID: mdl-23769672

ABSTRACT

ERdj5 is a member of the protein disulfide isomerase family of proteins localized to the endoplasmic reticulum (ER) of mammalian cells. To date, only a limited number of substrates for ERdj5 are known. Here we identify a number of endogenous substrates that form mixed disulfides with ERdj5, greatly expanding its client repertoire. ERdj5 previously had been thought to exclusively reduce disulfides in proteins destined for dislocation to the cytosol for degradation. However, we demonstrate here that for one of the identified substrates, the low-density lipoprotein receptor (LDLR), ERdj5 is required not for degradation, but rather for efficient folding. Our results demonstrate that the crucial role of ERdj5 is to reduce non-native disulfides formed during productive folding and that this requirement is dependent on its interaction with BiP. Hence, ERdj5 acts as the ER reductase, both preparing misfolded proteins for degradation and catalyzing the folding of proteins that form obligatory non-native disulfides.


Subject(s)
Cystine/metabolism , Endoplasmic Reticulum/enzymology , HSP40 Heat-Shock Proteins/physiology , Molecular Chaperones/physiology , Protein Processing, Post-Translational , Receptors, LDL/metabolism , Amino Acid Sequence , Catalytic Domain , Cell Line, Tumor , Gene Knockdown Techniques , HSP40 Heat-Shock Proteins/chemistry , Humans , Molecular Chaperones/chemistry , Proteasome Endopeptidase Complex/metabolism , Protein Binding , Protein Folding , Protein Interaction Domains and Motifs , Protein Transport , Proteolysis , RNA, Small Interfering/genetics , Receptors, LDL/chemistry
11.
Am J Pathol ; 177(5): 2323-33, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20847288

ABSTRACT

Reelin is a secreted, signaling protein associated with neuronal cell positioning and migration. Recently, reelin was found to be epigenetically silenced in gastric and pancreatic cancers in which down-regulation was associated with increased migratory ability and reduced survival. Here we analyzed reelin expression by immunohistochemistry in 17 normal breast tissue samples from reduction mammoplasties and in two independent tissue microarrays of 136 and more than 2000 breast cancer biopsy samples, respectively. Results were analyzed with regard to clinical parameters, including BRE (Bloom, Richardson, Elston) grade, nodal status, estrogen receptor and HER2 status, and overall survival. Reelin was expressed in the luminal epithelium and myoepithelium of the normal human breast but not in cancerous breasts. Loss of reelin protein expression correlated significantly with decreased survival (P=0.01) and positive lymph node status (P<0.001). By measuring reelin expression and promoter methylation status in 39 primary breast tumors, as well as in breast cancer-derived cell lines before and after decitabine treatment, we established that reelin expression levels correlated inversely with promoter methylation status, whereas demethylation increased reelin mRNA expression in vitro. Reelin overexpression in MDA-MB231 cells, as well as incubation with recombinant reelin, suppressed cell migration, invadopodia formation, and invasiveness in vitro. We conclude that reelin may play an important role in controlling invasiveness and metastatic potential of breast cancer cells and that its expression is controlled by promoter methylation.


Subject(s)
Breast Neoplasms/diagnosis , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Cell Adhesion Molecules, Neuronal/metabolism , Epigenesis, Genetic , Extracellular Matrix Proteins/metabolism , Nerve Tissue Proteins/metabolism , Serine Endopeptidases/metabolism , Cell Adhesion Molecules, Neuronal/genetics , Cell Line, Tumor , Cell Movement , Collagen Type I/metabolism , Extracellular Matrix Proteins/genetics , Female , HEK293 Cells , Humans , Neoplasm Invasiveness , Nerve Tissue Proteins/genetics , Prognosis , Promoter Regions, Genetic , Reelin Protein , Serine Endopeptidases/genetics
12.
Blood Cells Mol Dis ; 45(2): 117-23, 2010 Aug 15.
Article in English | MEDLINE | ID: mdl-20580290

ABSTRACT

The Runx transcription factors are essential for mammalian development, most notably in the haematopoietic and osteogenic lineages. Runx1 and its binding partner, CBFbeta, are frequently targeted in acute leukaemia but evidence is accumulating that all three Runx genes may have a role to play in a wider range of cancers, either as tumour promoters or tumour suppressors. Whilst Runx2 is renowned for its role as a master regulator of bone development we discuss here its expression pattern and putative functions beyond this lineage. Furthermore, we review the evidence that RUNX2 promotes neoplastic development in haematopoietic lineages and in advanced mammary and prostate cancer.


Subject(s)
Core Binding Factor Alpha 1 Subunit/metabolism , Core Binding Factor beta Subunit/metabolism , Genes, Tumor Suppressor , Hematologic Neoplasms/metabolism , Neoplasms, Glandular and Epithelial/metabolism , Oncogenes , Animals , Humans , Mice , Neoplasm Metastasis/genetics
13.
J Cell Physiol ; 206(1): 16-24, 2006 Jan.
Article in English | MEDLINE | ID: mdl-15920758

ABSTRACT

Mammary morphogenesis in the mouse is driven by specialized structures at the ends of the developing ducts, the terminal end buds (TEB). The mechanisms controlling the precise branching and spacing of the ducts are, as yet, unknown. To identify genes that are associated with migration of TEB and differentiation of the subtending ducts, we developed a novel method of isolating TEB and ducts free of stroma, and compared the gene expression profiles of these two isolates using oligonucleotide microarrays. Ninety one genes were upregulated in TEB compared to ducts. Three of these genes, Sprr1A, Sema3B, and BASP1, are associated with axonal growth and guidance. Two additional members of the Sprr family, Sprr2A and 2B, not previously associated with axonal growth, were also highly expressed in TEB. Expression of these genes was confirmed by RT-PCR and Western blotting, and the cellular distribution of Sprr1A and BASP1 was demonstrated by immunohistochemistry. Other semaphorins, including Sema3C, 4A, 4F and the cancer invasion associated Sema 4D were also expressed in the mouse mammary gland along with the semaphorin receptors, Plexins A2, A3, B2, and D1, and Neuropilins 1 and 2. These results are discussed in the context of other proteins expressed in the developing gland that are known to be downstream effectors of these signaling molecules. We suggest that these genes may influence ductal growth and morphogenesis in the developing mammary gland.


Subject(s)
Axons/metabolism , Mammary Glands, Animal , Morphogenesis , Signal Transduction/physiology , Animals , Calmodulin-Binding Proteins/genetics , Calmodulin-Binding Proteins/metabolism , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/metabolism , Cell Movement/physiology , Cornified Envelope Proline-Rich Proteins , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Female , Gene Expression Profiling , Gene Expression Regulation, Developmental , In Vitro Techniques , Mammary Glands, Animal/anatomy & histology , Mammary Glands, Animal/growth & development , Mammary Glands, Animal/physiology , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Inbred BALB C , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neuropilins/genetics , Neuropilins/metabolism , Oligonucleotide Array Sequence Analysis , Pregnancy , Protein Isoforms/genetics , Protein Isoforms/metabolism , Semaphorins/genetics , Semaphorins/metabolism
14.
Clin Cancer Res ; 11(19 Pt 1): 6872-9, 2005 Oct 01.
Article in English | MEDLINE | ID: mdl-16203777

ABSTRACT

PURPOSE: Microarray studies have linked Annexin A8 RNA expression to a "basal cell-like" subset of breast cancers, including BRCA1-related cancers, that are characterized by cytokeratin 5 (CK5) and CK17 expression and show poor prognosis. We assessed Annexin A8's contribution to the overall prognosis and its expression in normal, benign, and cancerous tissue and addressed Annexin A8's physiologic role in the mammary gland. EXPERIMENTAL DESIGN: Using microarrays and reverse transcription-PCR, the Annexin A8 expression was studied during mouse mammary gland development and in isolated mammary structures. Reverse transcription-PCR on cultured human luminal and basal cells, along with immunocytochemistry on normal and benign breast tissues, was used for cellular localization. Annexin A8's prognostic relevance and its coexpression with CK5 were assessed on tissue arrays of 1,631 cases of invasive breast cancer. Coexpression was further evaluated on a small cohort of 14 BRCA1-related breast cancers. RESULTS: Annexin A8 was up-regulated during mouse mammary gland involution and in pubertal ductal epithelium. Annexin A8 showed preferred expression in cultured basal cells but predominant luminal expression in normal human breast tissue in vivo. Hyperplasias and in situ carcinomas showed a strong staining of basal cells. Annexin A8 expression was significantly associated with grade (P < 0.0001), CK5 (P < 0.0001), and estrogen receptor status (P < 0.0001); 85.7% BRCA1-related breast tumors coexpressed Annexin A8 and CK5. CONCLUSION: Annexin A8 is involved in mouse mammary gland involution. In humans, it is a luminally expressed protein with basal expression in cell culture and in hyperplasia/ductal carcinoma in situ. Expression in invasive breast carcinomas has a significant effect on survival (P = 0.03) but is not independent of grade or CK5.


Subject(s)
Annexins/biosynthesis , Breast Neoplasms/metabolism , Breast Neoplasms/mortality , Gene Expression Regulation, Neoplastic , Mammary Glands, Animal/metabolism , Mammary Glands, Animal/pathology , Up-Regulation , Animals , Apoptosis , Carcinoma/metabolism , Carcinoma/pathology , Carcinoma, Intraductal, Noninfiltrating/pathology , Cohort Studies , Female , Genes, BRCA1 , Humans , Immunohistochemistry , Keratins/biosynthesis , Mice , Mutation , Oligonucleotide Array Sequence Analysis , Oligonucleotides/chemistry , Phenotype , Polymerase Chain Reaction , Prognosis , RNA/chemistry , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...